Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

President Trump wants to end homelessness in America. His plan? Make it easier to involuntarily treat people with serious ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

European regulators said that a Duchenne gene therapy should not be approved, imperiling the treatment that is also facing ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

The federal government has approved more than $4 billion in extra Medicaid funds that will be routed to hospitals, doctors, ...

Preauthorization is about to enter the lives of many seniors who have chosen traditional Medicare over MA, write former CMS ...

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the ...

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...

But it’s unclear if the evidence provided to support continued use of fluoridated supplements will matter. The FDA said in ...

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that ...